# HALT Progression of Polycystic Kidney Disease Study A

> **NCT00283686** · PHASE3 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 558 (actual)

## Conditions studied

- Kidney, Polycystic

## Interventions

- **DRUG:** Lisinopril
- **DRUG:** Telmisartan
- **DRUG:** Placebo
- **OTHER:** Standard Blood Pressure Control
- **OTHER:** Low Blood Pressure Control

## Key facts

- **NCT ID:** NCT00283686
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 558 (ACTUAL)
- **Last updated:** 2020-04-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00283686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00283686, "HALT Progression of Polycystic Kidney Disease Study A". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00283686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*